Application 204766

Type
ANDA
Sponsor
CIPLA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001EFAVIRENZEFAVIRENZTABLET;ORAL600MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
69097-301EfavirenzEfavirenzCipla USA Inc.ANDACurrent
69097-301EfavirenzEfavirenzCipla USA Inc.ANDACurrent
69097-301EfavirenzEfavirenzCipla USA Inc.ANDACurrent
70518-2962EfavirenzEfavirenzREMEDYREPACK INC.ANDACurrent
70518-2962EfavirenzEfavirenzREMEDYREPACK INC.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
48650ORIG2017-06-06